Luyao Ao

505 total citations
15 papers, 383 citations indexed

About

Luyao Ao is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Luyao Ao has authored 15 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Physiology. Recurrent topics in Luyao Ao's work include Pain Mechanisms and Treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Luyao Ao is often cited by papers focused on Pain Mechanisms and Treatments (4 papers), Neuroinflammation and Neurodegeneration Mechanisms (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Luyao Ao collaborates with scholars based in China. Luyao Ao's co-authors include Lin Zhou, Yunman Li, Weirong Fang, Yunyi Yan, Ya‐Hui Hu, Chengyuan Li, Jihua Liu, Wanting Li, Wanting Li and Cheng‐Yuan Li and has published in prestigious journals such as Neuroscience, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Luyao Ao

15 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luyao Ao China 13 177 107 84 55 48 15 383
Jiankang Fang Macao 11 243 1.4× 73 0.7× 58 0.7× 32 0.6× 42 0.9× 16 484
Asmaa Oun Netherlands 9 166 0.9× 60 0.6× 65 0.8× 16 0.3× 28 0.6× 14 395
Yan-ting Gu China 13 200 1.1× 53 0.5× 101 1.2× 28 0.5× 22 0.5× 26 463
Jiheng Zhan China 12 270 1.5× 40 0.4× 38 0.5× 59 1.1× 44 0.9× 24 502
Danyang Liu China 14 267 1.5× 57 0.5× 75 0.9× 45 0.8× 13 0.3× 44 520
Xiyu Mei China 11 231 1.3× 40 0.4× 126 1.5× 38 0.7× 28 0.6× 15 518
Wenjuan He China 14 315 1.8× 172 1.6× 73 0.9× 107 1.9× 28 0.6× 42 676

Countries citing papers authored by Luyao Ao

Since Specialization
Citations

This map shows the geographic impact of Luyao Ao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyao Ao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyao Ao more than expected).

Fields of papers citing papers by Luyao Ao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luyao Ao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyao Ao. The network helps show where Luyao Ao may publish in the future.

Co-authorship network of co-authors of Luyao Ao

This figure shows the co-authorship network connecting the top 25 collaborators of Luyao Ao. A scholar is included among the top collaborators of Luyao Ao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luyao Ao. Luyao Ao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ao, Luyao, Shencun Fang, Kexin Zhang, et al.. (2022). Sequence-dependent synergistic effect of aumolertinib-pemetrexed combined therapy on EGFR-mutant non-small-cell lung carcinoma with pre-clinical and clinical evidence. Journal of Experimental & Clinical Cancer Research. 41(1). 163–163. 6 indexed citations
2.
Wang, Qizhi, Haobin Li, Xin Rao, et al.. (2022). Therapeutic targeting of glutamate dehydrogenase 1 that links metabolic reprogramming and Snail-mediated epithelial–mesenchymal transition in drug-resistant lung cancer. Pharmacological Research. 185. 106490–106490. 29 indexed citations
3.
4.
Li, Wanting, et al.. (2020). Targeting pyroptosis to regulate ischemic stroke injury: Molecular mechanisms and preclinical evidences. Brain Research Bulletin. 165. 146–160. 34 indexed citations
5.
Li, Wanting, Luyao Ao, Lin Zhou, et al.. (2020). Protective Mechanism and Treatment of Neurogenesis in Cerebral Ischemia. Neurochemical Research. 45(10). 2258–2277. 18 indexed citations
6.
Ao, Luyao, Lin Zhou, Yunyi Yan, et al.. (2019). Therapeutic effects of JLX-001 on ischemic stroke by inducing autophagy via AMPK-ULK1 signaling pathway in rats. Brain Research Bulletin. 153. 162–170. 23 indexed citations
7.
Zhou, Lin, Luyao Ao, Yunyi Yan, et al.. (2019). JLX001 Ameliorates Ischemia/Reperfusion Injury by Reducing Neuronal Apoptosis via Down-Regulating JNK Signaling Pathway. Neuroscience. 418. 189–204. 13 indexed citations
8.
Zhou, Lin, Luyao Ao, Yunyi Yan, et al.. (2019). Levo-corydalmine Attenuates Vincristine-Induced Neuropathic Pain in Mice by Upregulating the Nrf2/HO-1/CO Pathway to Inhibit Connexin 43 Expression. Neurotherapeutics. 17(1). 340–355. 42 indexed citations
9.
Zhou, Lin, Luyao Ao, Yunyi Yan, et al.. (2019). The Therapeutic Potential of Chemokines in the Treatment of Chemotherapy- Induced Peripheral Neuropathy. Current Drug Targets. 21(3). 288–301. 16 indexed citations
10.
Zhou, Lin, Ya‐Hui Hu, Chengyuan Li, et al.. (2018). Levo-corydalmine alleviates vincristine-induced neuropathic pain in mice by inhibiting an NF-kappa B-dependent CXCL1/CXCR2 signaling pathway. Neuropharmacology. 135. 34–47. 59 indexed citations
11.
Yan, Yunyi, Luyao Ao, Lin Zhou, et al.. (2018). Therapeutic effects of JLX001 on cerebral ischemia through inhibiting platelet activation and thrombus formation in rats. Biomedicine & Pharmacotherapy. 106. 805–812. 15 indexed citations
12.
Ao, Luyao, Yunyi Yan, Lin Zhou, et al.. (2018). Immune Cells After Ischemic Stroke Onset: Roles, Migration, and Target Intervention. Journal of Molecular Neuroscience. 66(3). 342–355. 55 indexed citations
13.
Su, Mei, Lin Zhou, Yunyi Yan, et al.. (2017). Anti-ulcerogenic effect of KFP-H008 against ethanol-induced gastric ulcerviap38 MAPK/NF-κB pathway. RSC Advances. 7(78). 49423–49435. 16 indexed citations
14.
Yan, Yunyi, et al.. (2017). Research progress of mechanisms and drug therapy for neuropathic pain. Life Sciences. 190. 68–77. 40 indexed citations
15.
Su, Mei, Yunyi Yan, Lin Zhou, et al.. (2017). KFP-H008 blocks gastric acid secretion through inhibiting H+-K+-ATPase. European Journal of Pharmacology. 810. 112–119. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jiankang Fang Breakdown of academic impact, for papers by Asmaa Oun Breakdown of academic impact, for papers by Yan-ting Gu Breakdown of academic impact, for papers by Jiheng Zhan Breakdown of academic impact, for papers by Danyang Liu Breakdown of academic impact, for papers by Xiyu Mei Breakdown of academic impact, for papers by Wenjuan He
Rankless by CCL
2026